Medpace Holdings, Inc. Common Stock insider trading
MEDPfinancial statementsForm 4 filings on EDGAR138 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Medpace Holdings, Inc. Common Stock bought $0 of stock in the open market, and 7 sold $213M. Officers and directors accounted for $0 of purchases and $213M of sales. The last reported transaction was an open-market sale by Burwig Susan E on October 27, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 28, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $213MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
138 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | Burwig Susan E | Exec. VP, Operations | open-market sale | 3,940 | $677.00 | $3M | 54,012 | Oct 28, 2026 |
| Oct 26, 2026 | Burwig Susan E | Exec. VP, Operations | open-market sale | 16,060 | $677.00 | $11M | 57,624 | Oct 28, 2026 |
| Oct 26, 2026 | Burwig Susan E | Exec. VP, Operations | option exercise | 328 | $166.73 | $55K | 57,952 | Oct 28, 2026 |
| Oct 21, 2026 | Burwig Susan E | Exec. VP, Operations | option exercise | 2,700 | $166.73 | $450K | 73,684 | Oct 23, 2026 |
| Oct 12, 2026 | Burwig Susan E | Exec. VP, Operations | option exercise | 3,000 | $166.73 | $500K | 70,984 | Oct 14, 2026 |
| Oct 7, 2026 | Burwig Susan E | Exec. VP, Operations | option exercise | 2,000 | $166.73 | $333K | 67,984 | Oct 9, 2026 |
| Sep 30, 2026 | McCarthy Cornelius P. III | Director | option exercise | 28 | — | — | 12,303 | Oct 2, 2026 |
| Sep 30, 2026 | Kraft Robert O. | Director | option exercise | 32 | — | — | 987 | Oct 2, 2026 |
| Sep 30, 2026 | Carley Brian T | Director | option exercise | 36 | — | — | 27,861 | Oct 2, 2026 |
| Sep 30, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 21,966 | $625.47 | $14M | 338,225 | Oct 1, 2026 |
| Sep 29, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 26,701 | $621.02 | $17M | 360,191 | Oct 1, 2026 |
| Sep 28, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 2,410 | $620.07 | $1M | 386,892 | Sep 29, 2026 |
| Sep 25, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 154 | $620.60 | $96K | 389,302 | Sep 29, 2026 |
| Sep 24, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 27,833 | $621.33 | $17M | 389,456 | Sep 25, 2026 |
| Sep 23, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 16,083 | $628.64 | $10M | 417,289 | Sep 25, 2026 |
| Sep 22, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 49,018 | $628.11 | $31M | 433,372 | Sep 23, 2026 |
| Sep 21, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 21,883 | $623.29 | $14M | 482,390 | Sep 23, 2026 |
| Sep 17, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 10,880 | $620.40 | $7M | 504,273 | Sep 21, 2026 |
| Sep 16, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 8,770 | $621.29 | $5M | 515,153 | Sep 17, 2026 |
| Sep 15, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 15,971 | $620.84 | $10M | 523,923 | Sep 17, 2026 |
| Sep 15, 2026 | Burwig Susan E | Exec. VP, Operations | option exercise | 3,000 | $166.73 | $500K | 65,984 | Sep 17, 2026 |
| Aug 27, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 650 | $620.27 | $403K | 539,894 | Aug 31, 2026 |
| Aug 26, 2026 | Kraft Robert O. | Director | option exercise | 3,858 | $84.36 | $325K | 4,813 | Aug 28, 2026 |
| Aug 26, 2026 | Kraft Robert O. | Director | open-market sale | 3,858 | $617.81 | $2M | 955 | Aug 28, 2026 |
| Aug 26, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 4,000 | $620.03 | $2M | 540,544 | Aug 27, 2026 |
| Aug 25, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 673 | $620.38 | $418K | 544,544 | Aug 27, 2026 |
| Aug 24, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 1,983 | $620.23 | $1M | 545,217 | Aug 25, 2026 |
| Aug 21, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 13,995 | $624.45 | $9M | 547,200 | Aug 25, 2026 |
| Aug 20, 2026 | Brady Kevin M. | CFO & Treasurer | option exercise | 3,400 | $138.87 | $472K | 16,230 | Aug 24, 2026 |
| Aug 20, 2026 | Brady Kevin M. | CFO & Treasurer | open-market sale | 3,400 | $625.24 | $2M | 12,830 | Aug 24, 2026 |
| Aug 20, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 27,174 | $618.79 | $17M | 561,195 | Aug 21, 2026 |
| Aug 19, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 15,609 | $606.47 | $9M | 588,369 | Aug 21, 2026 |
| Aug 19, 2026 | Carley Brian T | Director | open-market sale | 5,000 | $608.63 | $3M | 27,825 | Aug 21, 2026 |
| Aug 19, 2026 | Davenport Fred B JR | Director | option exercise | 1,903 | $133.87 | $255K | 5,401 | Aug 21, 2026 |
| Aug 19, 2026 | Davenport Fred B JR | Director | option exercise | 3,858 | $84.36 | $325K | 9,259 | Aug 21, 2026 |
| Aug 19, 2026 | Davenport Fred B JR | Director | option exercise | 1,822 | $164.68 | $300K | 11,081 | Aug 21, 2026 |
| Aug 19, 2026 | Davenport Fred B JR | Director | open-market sale | 7,283 | $606.15 | $4M | 3,798 | Aug 21, 2026 |
| Aug 13, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 458 | $600.39 | $275K | 603,978 | Aug 14, 2026 |
| Aug 12, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 11,366 | $601.53 | $7M | 604,436 | Aug 14, 2026 |
| Aug 11, 2026 | McCarthy Cornelius P. III | Director | open-market sale | 1,140 | $605.37 | $690K | 12,275 | Aug 13, 2026 |
| Aug 11, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 17,610 | $605.11 | $11M | 615,802 | Aug 12, 2026 |
| Aug 10, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 5,534 | $601.53 | $3M | 633,412 | Aug 12, 2026 |
| Aug 7, 2026 | McCarthy Cornelius P. III | Director | option exercise | 3,858 | $84.36 | $325K | 14,210 | Aug 11, 2026 |
| Aug 7, 2026 | McCarthy Cornelius P. III | Director | open-market sale | 795 | $585.07 | $465K | 13,415 | Aug 11, 2026 |
| Jul 28, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 3,510 | $600.01 | $2M | 638,946 | Jul 29, 2026 |
| Jul 28, 2026 | Burwig Susan E | Exec. VP, Operations | open-market sale | 7,500 | $600.00 | $5M | 62,984 | Jul 29, 2026 |
| Jul 27, 2026 | Troendle August J. | President & CEO, Director, 10% owner | open-market sale | 3,728 | $600.85 | $2M | 642,456 | Jul 29, 2026 |
| Jun 30, 2026 | McCarthy Cornelius P. III | Director | option exercise | 28 | — | — | 10,352 | Jul 2, 2026 |
| Jun 30, 2026 | Kraft Robert O. | Director | option exercise | 33 | — | — | 955 | Jul 2, 2026 |
| Jun 30, 2026 | Carley Brian T | Director | option exercise | 36 | — | — | 32,825 | Jul 2, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Troendle August J. | President & CEO, Director, 10% owner | Sep 30, 2026 | open-market sale | 338,225 | — | $358M (39) | 0 of 39 |
| Burwig Susan E | Exec. VP, Operations | Oct 27, 2026 | open-market sale | 54,012 | — | $41M (5) | 0 of 5 |
| Geiger Jesse J | President | Mar 17, 2026 | open-market sale | 15,000 | — | $27M (2) | 1 of 2 |
| Ewald Stephen P | General Counsel & Corp. Secy. | May 28, 2026 | option exercise | 36,692 | — | $7M (1) | 0 of 1 |
| Kraft Robert O. | Director | Sep 30, 2026 | option exercise | 987 | — | $6M (2) | 0 of 2 |
| Davenport Fred B JR | Director | Aug 19, 2026 | option exercise | 5,401 | — | $4M (1) | 0 of 1 |
| Brady Kevin M. | CFO & Treasurer | Aug 20, 2026 | option exercise | 16,230 | — | $4M (2) | 0 of 2 |
| Carley Brian T | Director | Sep 30, 2026 | option exercise | 27,861 | — | $3M (1) | 0 of 1 |
| McCarthy Cornelius P. III | Director | Sep 30, 2026 | option exercise | 12,303 | — | $1M (2) | 0 of 2 |
Questions
Are Medpace Holdings, Inc. Common Stock insiders buying or selling?
Over the twelve months to November 1, 2026, 9 insiders at Medpace Holdings, Inc. Common Stock sold $453M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $453M. Only open-market purchases and sales are counted.
Who sold the most Medpace Holdings, Inc. Common Stock stock in the last year?
Troendle August J. (President & CEO, Director, 10% owner) sold $358M in 39 open-market sales over the twelve months to November 1, 2026.
Do Medpace Holdings, Inc. Common Stock executives sell under 10b5-1 plans?
1 of the 55 open-market sales in the last twelve months (2%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Medpace Holdings, Inc. Common Stock
- Medpace Holdings, Inc. Common Stock financial statements
- 1 tracked fund holding MEDP
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.